NEW YORK (GenomeWeb) – Applied BioCode today said it has expanded an existing licensing and supply agreement with PerkinElmer for the use of Applied BioCode's Barcoded Magnetic Bead technology. 

The amended non-exclusive deal provides PerkinElmer access to Applied BioCode's 4,096-plex BMB patents, as well as the BioCode MDx 3000 high-throughput system for the Asian markets. PerkinElmer will develop market-specific multiplexed molecular diagnostics for infectious diseases for the BioCode MDx 3000 platform and distribute them into select Asian markets, Applied BioCode said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.